Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme

Daniel Farray; Manmeet S. Ahluwalia; Josette Snyder; Gene H. Barnett; Bruce H. Cohen; John H. Suh; David M. Peereboom

doi:10.1007/S10637-005-2464-5

Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme

Daniel Farray, Manmeet S. Ahluwalia, Josette Snyder, Gene H. Barnett, Bruce H. Cohen, John H. Suh, David M. Peereboom

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Investigational New Drugs
Volume	24
DOIs	https://doi.org/10.1007/S10637-005-2464-5
State	Published - May 1 2006

Disciplines

Medicine and Health Sciences
Oncology
Surgery
Internal Medicine

Access to Document

10.1007/S10637-005-2464-5License: Unspecified

Cite this

@article{b0bd86c271584150bf22c5eecf6380a6,

title = "Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme",

author = "Daniel Farray and Ahluwalia, {Manmeet S.} and Josette Snyder and Barnett, {Gene H.} and Cohen, {Bruce H.} and Suh, {John H.} and Peereboom, {David M.}",

note = "Purpose To evaluate the efficacy of 9-amino [20s] camptothecin (9-AC) given before radiation therapy to patients with newly diagnosed glioblastoma multiforme (GBM). Methods Eligible patients had newly diagnosed GBM who had residual measurable contrast-enhancing tumor.",

year = "2006",

month = may,

day = "1",

doi = "10.1007/S10637-005-2464-5",

language = "American English",

volume = "24",

journal = "Investigational New Drugs",

}

TY - JOUR

T1 - Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme

AU - Farray, Daniel

AU - Ahluwalia, Manmeet S.

AU - Snyder, Josette

AU - Barnett, Gene H.

AU - Cohen, Bruce H.

AU - Suh, John H.

AU - Peereboom, David M.

N1 - Purpose To evaluate the efficacy of 9-amino [20s] camptothecin (9-AC) given before radiation therapy to patients with newly diagnosed glioblastoma multiforme (GBM). Methods Eligible patients had newly diagnosed GBM who had residual measurable contrast-enhancing tumor.

PY - 2006/5/1

Y1 - 2006/5/1

UR - https://europepmc.org/article/MED/16086097

U2 - 10.1007/S10637-005-2464-5

DO - 10.1007/S10637-005-2464-5

M3 - Article

VL - 24

JO - Investigational New Drugs

JF - Investigational New Drugs

ER -

Pre-irradiation 9-Amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme

Disciplines

Access to Document

Other files and links

Cite this